| Date Filed | Type | Description |
| 07/12/2023 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 25,000 shares
@ $0
Granted 30,000 options to buy
@ $1.32, valued at
$39.6k
|
|
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4/A
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on Astria Therapeutics, Inc.|
Txns:
| Granted 8,333 options to buy
@ $0 |
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $2.04, valued at
$204k
|
|
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2020 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Granted 15,228 options to buy
@ $1.97, valued at
$30k
|
|
| 06/12/2020 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 7,500 options to buy
@ $6.17, valued at
$46.3k
|
|
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2019 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 55,000 options to buy
@ $2.02, valued at
$111.1k
|
|
| 02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2019 |
4/A
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 2,800 options to buy
@ $0 |
|
| 01/04/2019 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC|
Txns:
| Granted 2,800 options to buy
@ $4.9, valued at
$13.7k
|
|
| 01/04/2019 |
3
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 3 on CATABASIS PHARMACEUTICALS INC |
| 09/28/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2018 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $3.98, valued at
$119.4k
|
|
| 11/02/2017 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC|
Txns:
| Granted 80,000 options to buy
@ $3.8, valued at
$304k
|
|
| 11/02/2017 |
3
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 3 on RIGEL PHARMACEUTICALS INC |
| 10/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/03/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 10/26/2016 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Unknown transaction of 2,092 shares
@ $9, valued at
$18.8k
Disposed/sold 8,330 shares
@ $9, valued at
$75k
Disposed/sold 7,915 options to buy
@ $5.22, valued at
$41.3k
|
|
| 06/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/21/2016 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on ImmunoCellular Therapeutics, Ltd.|
Txns:
| Granted 156,750 options to buy
@ $0.24, valued at
$37.6k
|
|
| 06/20/2016 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Granted 40,541 options to buy
@ $0.74, valued at
$30k
|
|
| 06/13/2016 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $13.995, valued at
$419.9k
|
|
| 04/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/01/2013 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Granted 13,275 options to buy
@ $2.26, valued at
$30k
|
|
| 06/28/2013 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $5.13, valued at
$153.9k
|
|
|